Used in clinical research and therapeutic development for inflammatory diseases, this antibody targets interleukin-1 alpha (IL-1α) to block its pro-inflammatory activity. It has been investigated in conditions such as cancer, rheumatoid arthritis, and skin disorders where IL-1α plays a role in disease progression. By neutralizing IL-1α, it helps reduce inflammation, pain, and tissue damage. It is also used as a reference standard in immunoassays and bioassay development to evaluate the potency and specificity of other anti-IL-1α agents.